Skip to main content
Premium Trial:

Request an Annual Quote

CDC and FDA in Transition

President-elect Barack Obama is about to name new heads of the CDC and FDA, says this story in the Wall Street Journal. Julie Gerberding will step down as CDC director to be replaced by William Gimson III, the CDC's COO, for the transition. Possible permanent choices include James Marks, a former senior CDC official and now a senior vice president at the Robert Wood Johnson Foundation; Helene Gayle, former CDC director for HIV/AIDS and president and CEO of CARE; and Thomas Frieden, commissioner of the New York City Department of Health and Mental Hygiene.

FDA's current science chief, Frank Torti, will serve as acting director until a permanent replacement is named. He was chosen to fill the temp spot over Janet Woodcock, director of the drug division who is currently "under fire from Congress in relation to several drug-safety issues, including the importation of contaminated heparin from China," reports the WSJ.

The Scan

Billions for Antivirals

The US is putting $3.2 billion toward a program to develop antivirals to treat COVID-19 in its early stages, the Wall Street Journal reports.

NFT of the Web

Tim Berners-Lee, who developed the World Wide Web, is auctioning its original source code as a non-fungible token, Reuters reports.

23andMe on the Nasdaq

23andMe's shares rose more than 20 percent following its merger with a special purpose acquisition company, as GenomeWeb has reported.

Science Papers Present GWAS of Brain Structure, System for Controlled Gene Transfer

In Science this week: genome-wide association study ties variants to white matter stricture in the brain, and more.